Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability of Fenofibrate/Metformin FDC in T2D and Dyslipidemia
NCT00348725Phase 3Completed
- Sponsor
- Solvay
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate + metformin in type 2 diabetes mellitus (T2DM), dyslipidemia, sponsored by Solvay. Started Apr 2005; status: completed.
02
Drugs
fenofibrate + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)dyslipidemia
Beyond the preview
Go deeper on NCT00348725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348725.